Kennedy: “HHS has determined that mRNA technology poses more risk than benefits” in humans for respiratory viruses.
Kennedy shut down $500 million in mRNA vaccine contracts. “HHS has determined that mRNA technology poses more risk than benefits for these respiratory viruses,” he said Tuesday. The decision followed a multi-week review of 22 BARDA-funded projects targeting COVID and …